Ironwood Pharmaceuticals (IRWD) Revenue: 2010-2025
Historic Revenue for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Sep 2025 value amounting to $122.1 million.
- Ironwood Pharmaceuticals' Revenue rose 33.26% to $122.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $339.0 million, marking a year-over-year decrease of 10.42%. This contributed to the annual value of $351.4 million for FY2024, which is 20.63% down from last year.
- According to the latest figures from Q3 2025, Ironwood Pharmaceuticals' Revenue is $122.1 million, which was up 43.20% from $85.2 million recorded in Q2 2025.
- In the past 5 years, Ironwood Pharmaceuticals' Revenue ranged from a high of $122.1 million in Q3 2025 and a low of $41.1 million during Q1 2025.
- Over the past 3 years, Ironwood Pharmaceuticals' median Revenue value was $94.4 million (recorded in 2024), while the average stood at $94.8 million.
- Examining YoY changes over the last 5 years, Ironwood Pharmaceuticals' Revenue showed a top increase of 33.26% in 2025 and a maximum decrease of 45.05% in 2025.
- Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Revenue stood at $117.1 million in 2021, then decreased by 8.48% to $107.2 million in 2022, then increased by 9.66% to $117.6 million in 2023, then declined by 22.98% to $90.5 million in 2024, then spiked by 33.26% to $122.1 million in 2025.
- Its Revenue stands at $122.1 million for Q3 2025, versus $85.2 million for Q2 2025 and $41.1 million for Q1 2025.